GlassScriptPhysician profile
Ruth Leo
NPI 1215253653
$2,481.31
in general payments reported to CMS, 2019-2025
18 companies · $426 in 2025
The $426 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $377 · 2022: $498 · 2023: $681 · 2024: $499 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,606.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $288.16 | 2024-2025 | Onpattro, Oxlumo, Givlaari |
| Teva Pharmaceuticals USA, INC. | $244.62 | 2021 | |
| Abbott Laboratories | $235.67 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Astrazeneca Pharmaceuticals LP | $214.45 | 2022-2025 | Fasenra |
| Phathom Pharmaceuticals, INC. | $202.99 | 2024 | Voquezna |
| Heartflow, INC. | $187.12 | 2022 | |
| Novo Nordisk INC | $130.00 | 2023 | Wegovy |
| Gilead Sciences, INC. | $127.86 | 2025 | Descovy |
| Coloplast Corp | $119.10 | 2024 | |
| Esperion Therapeutics, INC. | $113.52 | 2021 | |
| Amgen INC. | $112.36 | 2022 | |
| Amarin Pharma, INC. | $107.61 | 2023 | |
| Idorsia Pharmaceuticals US INC | $107.59 | 2023 | Quviviq |
| Biogen, INC. | $100.00 | 2023 | Spinraza |
| Haemonetics Corporation | $97.92 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cipher Pharmaceuticals US LLC | $55.29 | 2025 | Natroba, Spinosad |
| Novartis Pharmaceuticals Corporation | $18.72 | 2021 | |
| Abbvie INC. | $18.33 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Leo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.